These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8403618)

  • 1. Gonadotropin-releasing hormone and its analogues: applications in gynecology.
    Garcia JE
    Clin Obstet Gynecol; 1993 Sep; 36(3):719-26. PubMed ID: 8403618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders.
    Padilla SL; Dugan K; Maruschak V; Shalika S; Smith RD
    Fertil Steril; 1996 Apr; 65(4):796-9. PubMed ID: 8654641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization.
    San Roman GA; Surrey ES; Judd HL; Kerin JF
    Fertil Steril; 1992 Oct; 58(4):744-9. PubMed ID: 1426320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization.
    Garcia JE; Padilla SL; Bayati J; Baramki TA
    Fertil Steril; 1990 Feb; 53(2):302-5. PubMed ID: 2105247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteal phase consequences of low-dose gonadotropin-releasing hormone agonist therapy in nonluteal-supported in vitro fertilization cycles.
    Long CA; Sopelak VM; Lincoln SR; Cowan BD
    Fertil Steril; 1995 Sep; 64(3):573-6. PubMed ID: 7641913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of ovulation with luprolide acetate and human menopausal gonadotropin.
    Lewinthal D; Taylor PJ; Pattinson HA; Corenblum B
    Fertil Steril; 1988 Apr; 49(4):585-8. PubMed ID: 3127242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Lupron screening test: tailoring the use of leuprolide acetate in ovarian stimulation for in vitro fertilization.
    Padilla SL; Smith RD; Garcia JE
    Fertil Steril; 1991 Jul; 56(1):79-83. PubMed ID: 1906020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of hCG versus GnRH analog for releasing oocytes following ultra low-dose gonadotropin stimulation.
    Check JH; Vetter BH; Weiss W
    Gynecol Endocrinol; 1993 Jun; 7(2):115-22. PubMed ID: 8213225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of gonadotrophin-releasing hormone agonists administered as desensitizing or flare protocols on hormonal function in the luteal phase of hyperstimulated cycles.
    Norman RJ; Warnes GM; Wang X; Kirby CA; Matthews CD
    Hum Reprod; 1991 Feb; 6(2):206-13. PubMed ID: 1905309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
    Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
    Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which luteal phase support is better for each IVF stimulation protocol to achieve the highest pregnancy rate? A superiority randomized clinical trial.
    Gizzo S; Andrisani A; Esposito F; Noventa M; Di Gangi S; Angioni S; Litta P; Gangemi M; Nardelli GB
    Gynecol Endocrinol; 2014; 30(12):902-8. PubMed ID: 25268567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of using ganirelix acetate versus a 4-day follicular phase leuprolide acetate protocol in unselected women undergoing in vitro fertilization.
    Posada MN; Vlahos NP; Jurema MW; Bracero NJ; Wallach EE; Garcia JE
    Fertil Steril; 2003 Jul; 80(1):103-10. PubMed ID: 12849810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Fatemi HM; Polyzos NP; van Vaerenbergh I; Bourgain C; Blockeel C; Alsbjerg B; Papanikolaou EG; Humaidan P
    Fertil Steril; 2013 Sep; 100(3):742-7. PubMed ID: 23806846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pregnancy rates in an IVF program. Use of the flare-up protocol after failure with long regimens of GnRH-a.
    Karacan M; Erkan H; Karabulut O; Sarikamiş B; Camlibel T; Benhabib M
    J Reprod Med; 2001 May; 46(5):485-9. PubMed ID: 11396377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteal phase estradiol versus luteal phase estradiol and antagonist protocol for controlled ovarian stimulation before in vitro fertilization in poor responders.
    Elassar A; Mann JS; Engmann L; Nulsen J; Benadiva C
    Fertil Steril; 2011 Jan; 95(1):324-6. PubMed ID: 20797708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leuprolide acetate for inducing ovulation in women undergoing ovarian stimulation.
    diDonato P; Nola VF; Pittman TV; Marr V; Stubbs C; Meldrum DR
    J Reprod Med; 1995 Oct; 40(10):715-6. PubMed ID: 8551474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix.
    Tavaniotou A; Albano C; Smitz J; Devroey P
    Hum Reprod; 2001 Apr; 16(4):663-7. PubMed ID: 11278214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.